The Development of Biocatalysis as a Tool for Drug Discovery

被引:12
|
作者
Schwarz, Jenny [1 ]
Rosenthal, Katrin [1 ]
Snajdrova, Radka [2 ]
Kittelmann, Matthias [3 ]
Lutz, Stephan [1 ]
机构
[1] TU Dortmund Univ, Chair Bioproc Engn, Emil Figge Str 66, D-44227 Dortmund, Germany
[2] Novartis Pharma AG, Global Discovery Chem, Lichtstr, CH-4056 Basel, Switzerland
[3] Novartis Pharma AG, Inst BioMed Res, Lichtstr, CH-4056 Basel, Switzerland
关键词
Biocatalysis; Chiral building blocks; Drug metabolites; Natural product modifications; Pharmacological activity; ENZYMATIC-SYNTHESIS; CHEMOENZYMATIC SYNTHESIS; ESCHERICHIA-COLI; ALDEHYDE OXIDASE; AMIDOHYDROLASE; RECOMBINANT; METABOLISM; ENZYMES; REGENERATION; PURIFICATION;
D O I
10.2533/chimia.2020.368
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Enzymes are versatile biocatalysts capable of performing selective reactions. The advantages of enzymes in comparison to classical chemistry including chemical catalysts are the generally milder process conditions and avoidance of harmful reactants. Their high selectivity and specificity are especially beneficial for the enzymatic synthesis of new products with potential applications in drug research. Therefore, in the past decades, the utilization of isolated enzymes or whole-cell biocatalysts has spread through a growing number of biotechnological industries. The applications comprise the production of chiral building blocks for the pharmaceutical and fine chemical industry, the enzymatic synthesis of drug metabolites for testing of toxicity, function, biological activity, degradation and the production of biocatalytically modified natural products, which all play a role in drug discovery. Especially Oreste Ghisalba's contributions, which paved the way for the industrial use of enzymes, will be considered in this review.
引用
收藏
页码:368 / 377
页数:10
相关论文
共 50 条
  • [1] Biocatalysis in drug discovery and development
    Fryszkowska, Anna
    Devine, Paul N.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2020, 55 : 151 - 160
  • [2] Biocatalysis in drug discovery and development
    Chen Yijun
    Wu Xuri
    [J]. PROGRESS IN CHEMISTRY, 2007, 19 (12) : 1947 - 1954
  • [3] Biocatalysis in drug discovery and drug development-Reimaging the manufacture of medicine at Novartis
    Snajdrova, Radka
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [4] Morphogenics as a tool for target discovery and drug development
    Nicolaides, NC
    Ebel, W
    Kline, B
    Chao, QM
    Routhier, E
    Sass, PM
    Grasso, L
    [J]. TUMOR PROGRESSION AND THERAPEUTIC RESISTANCE, 2005, 1059 : 86 - 96
  • [5] Combinatorial biocatalysis: a natural approach to drug discovery
    Michels, PC
    Khmelnitsky, YL
    Dordick, JS
    Clark, DS
    [J]. TRENDS IN BIOTECHNOLOGY, 1998, 16 (05) : 210 - 215
  • [6] Combinatorial biocatalysis for drug discovery and optimization.
    Michels, PC
    Khmelnitsky, YL
    Dordick, JS
    Clark, DS
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 85 - BIOT
  • [7] Harnessing biocatalysis as a green tool in antibiotic synthesis and discovery
    Fernandes, Guilherme F. S.
    Kim, Seong-Heun
    Castagnolo, Daniele
    [J]. RSC ADVANCES, 2024, 14 (41) : 30396 - 30410
  • [8] Molecular imaging : a powerful tool for drug discovery and development
    Saji, Hideo
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 : 33 - 34
  • [9] Is it time for biocatalysis in fragment-based drug discovery?
    Ramsden, Jeremy I.
    Cosgrove, Sebastian C.
    Turner, Nicholas J.
    [J]. CHEMICAL SCIENCE, 2020, 11 (41) : 11104 - 11112
  • [10] Biocatalysis for green chemistry and drug development
    Chen Zhenming
    Liu Jinhua
    Tao Junhua
    [J]. PROGRESS IN CHEMISTRY, 2007, 19 (12) : 1919 - 1927